Deng H L, Zhang J T
Institute of Materia Medica, Chinese Academy of Medical Sciences, Bejing.
Chin Med J (Engl). 1991 May;104(5):395-8.
It has been reported that Ginsenoside can increase body resistance to many harmful factors and protect tissues from damage when an organism is in stress. To understand the mechanism of this action, a study on the antioxidative effect of Ginsenoside Rb1 and Rg1 was carried out. Results showed that Ginsenoside Rb1 and Rg1 could inhibit lipid peroxidation of rat liver and brain microsomes and that Rb1, at the final concentration of 10(-4)-10(-3) mol/L, could scavenge O2-. induced by liver microsome-NADPH-gossypol system. In in vivo experiment, Rb1, at a dose of 50 and 25 mg/kg/day x 3 ip, inhibited MDA formation in liver homogenate of rats by 26.8% (P less than 0.05) and increased the activities of catalase and GSH peroxidase by 47.2% (P less than 0.001) and 96.4% (P less than 0.001), respectively. However, no change in the activity of superoxide dismutase was found in liver cytosol of rats treated with Rb1.
据报道,人参皂苷能增强机体对多种有害因素的抵抗力,并在机体处于应激状态时保护组织免受损伤。为了解其作用机制,对人参皂苷Rb1和Rg1的抗氧化作用进行了研究。结果表明,人参皂苷Rb1和Rg1可抑制大鼠肝和脑微粒体的脂质过氧化,且终浓度为10(-4)-10(-3)mol/L的Rb1可清除肝微粒体-NADPH-棉酚系统诱导产生的O2-。在体内实验中,腹腔注射剂量为50和25mg/kg/天×3天的Rb1可使大鼠肝匀浆中丙二醛(MDA)的生成量减少26.8%(P<0.05),过氧化氢酶和谷胱甘肽过氧化物酶的活性分别提高47.2%(P<0.001)和96.4%(P<0.001)。然而,用Rb1处理的大鼠肝胞液中超氧化物歧化酶的活性未发现变化。